Accriva Diagnostics, Inc. recalls
5 recall notices naming Accriva Diagnostics, Inc. since January 2025, in United States. The most recent was published 11 Nov 2026.
Latest recalls (5)
- Accriva Diagnostics, Inc. recalls Hemochron Jr.FDAMicrocoagulation test used to evaluate low dose heparin anticoagulation has a mispositioned or absent clot activating reagent, which may result in…
- Accriva Diagnostics, Inc. recalls directCHECK ACT-LR whole blood quality controlFDAAssayed Whole blood control contains labeling with incorrect performance range.
- Accriva Diagnostics, Inc. recalls Hemochron Activated Clotting Time Low-Range Test CuvetteFDATest cuvettes, used with an assay for monitoring heparin anticoagulation, may have a foreign object that has sharp edges and could pose a risk of…
- Accriva Diagnostics, Inc. recalls VerifyNow PRUTest Platelet Reactivity Test REF 85225 UDI-DI codeFDADue to an device without a premarket clearance being incorrectly package and distributed.
- Accriva Diagnostics, Inc. recalls VerifyNow P2Y12 Platelet Reactivity TestFDAPlatelet Reactivity Test distributed without appropriate US-FDA market clearance; if used healthcare personnel could use the baseline PRUTest…